Top Markets
Coin of the day
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Peringkat dalam Saham #17486
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Harga Saham
$0.8034
Kapitalisasi Pasar
$236.69M
Perubahan (1 hari)
-8.69%
Perubahan (1 tahun)
-22.00%
Negara
US
Perdagangan Invivyd, Inc. (IVVD)

Kategori

Riwayat harga saham Invivyd, Inc. (IVVD)
Harga penutupan tertinggi: $0.84 pada 2026-09-01

Harga penutupan terendah: $27.68 pada 2021-08-01
Riwayat harga saham Invivyd, Inc. dari 2021 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -37.40%
2025 355.72%
2024 -79.42%
2023 46.08%
2022 -91.63%
2021 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$550.79 37.35%
US
$1.05K 48.18%
NL
$147.97 511.69%
US
$122.21 -10.03%
AU
$757.71 8.20%
CH